[1] THEOCHARIS AD, SKANDALIS SS, GIALELI C, et al. Extracellular matrix structure. Adv Drug Deliv Rev. 2016;97:4-27.
[2] BONNANS C, CHOU J, WERB Z. Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol. 2014; 15(12):786-801.
[3] SUN Z, GUO SS, FÄSSLER R. Integrin-mediated mechanotransduction. J Cell Biol. 2016;215(4):445-456.
[4] ZHU J, LUO BH, XIAO T, et al. Structure of a complete integrin ectodomain in a physiologic resting state and activation and deactivation by applied forces. Mol cell.2008;32(6):849-861.
[5] RAY SJ, FRANKI SN, PIERCE RH, et al. The collagen binding alpha1beta1 integrin VLA-1 regulates CD8 T cell-mediated immune protection against heterologous influenza infection. Immunity. 2004;20(2):167-179.
[6] DANGERFIELD J, LARBI KY, HUANG MT, et al. PECAM-1 (CD31) homophilic interaction up-regulates alpha6beta1 on transmigrated neutrophils in vivo and plays a functional role in the ability of alpha6 integrins to mediate leukocyte migration through the perivascular basement membrane. J Exp Med.2002;196(9): 1201-1211.
[7] CHOU J, CHAN MF, WERB Z. Metalloproteinases: A functional pathway for myeloid cells. Microbiol Spectr. 2016;4(2):10.
[8] RICARD-BLUM S. The collagen family. Cold Spring Harbor Perspect Biol.2011;3(1):a004978.
[9] JABŁOŃSKA-TRYPUĆ A, MATEJCZYK M, ROSOCHACKI S. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.J Enzyme Inhib Med Chem.2016;31(sup1): 177-183.
[10] WEBSTER NL, CROWE SM. Matrix metalloproteinases, their production by monocytes and macrophages and their potential role in HIV-related diseases.J Leukoc Biol.2006;80(5):1052-1066.
[11] WANG Y, CHU Y, YUE B, et al. Adipose-derived mesenchymal stem cells promote osteosarcoma proliferation and metastasis by activating the STAT3 pathway. Oncotarget. 2017;8(14): 23803-23816.
[12] NABHA SM, DOSSANTOS EB, YAMAMOTO HA, et al. Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.Int J Cancer. 2008;122(11):2482-2490.
[13] KIM KH, BURKHART K, CHEN P, et al. Tissue inhibitor of metalloproteinase-1 deficiency amplifies acute lung injury in bleomycin-exposed mice.Am J Respir Cell Mol Biol.2005; 33(3): 271-279.
[14] SCHAEFER L, SCHAEFER RM. Proteoglycans: From structural compounds to signaling molecules.Cell Tissue Res.2010;339(1): 237-246.
[15] TIAN X, AZPURUA J, HINE C, et al. High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature.2013;499(7458):346-349.
[16] LEE-SAYER SS, DONG Y, ARIF AA, et al. The where, when, how, and why of hyaluronan binding by immune cells.Front Immunol. 2015;6:150.
[17] TOLG C, MCCARTHY JB, YAZDANI A, et al. Hyaluronan and RHAMM in wound repair and the “cancerization” of stromal tissues. Biomed Res Int. 2014;2014:103923
[18] TEDER P, VANDIVIER RW, JIANG D, et al. Resolution of lung inflammation by CD44. Science. 2002;296(5565):155-158.
[19] EVANKO SP, CHAN CK, JOHNSON PY, et al. The biochemistry and immunohistochemistry of versican. Methods Cell Biol.2018; 143:261-279.
[20] WIGHT TN. Provisional matrix: A role for versican and hyaluronan. Matrix Biol. 2017;60-61:38-56.
[21] COULSON-THOMAS VJ, GESTEIRA TF, HASCALL V, et al. Umbilical cord mesenchymal stem cells suppress host rejection: The role of the glycocalyx. J Biol Chem. 2014;289(34):23465-23481.
[22] SARRAZIN S, LAMANNA WC, ESKO JD. Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol. 2011;3(7): a004952.
[23] WEBER M, HAUSCHILD R, SCHWARZ J, et al. Interstitial dendritic cell guidance by haptotactic chemokine gradients. Science.2013;339(6117):328-332.
[24] COLLINS LE, TROEBERG L. Heparan sulfate as a regulator of inflammation and immunity. J Leukoc Biol. 2019;105(1):81-92.
[25] HALLMANN R, HORN N, SELG M, et al. Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev. 2005;85(3):979-1000.
[26] YADAV R, LARBI KY, YOUNG RE, et al. Migration of leukocytes through the vessel wall and beyond. Thromb Haemost. 2003; 90(4):598-606.
[27] WU C, IVARS F, ANDERSON P, et al. Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med.2009;15(5):519-527.
[28] DUITMAN EH, ORINSKA Z, BULFONE-PAUS S. Mechanisms of cytokine secretion: A portfolio of distinct pathways allows flexibility in cytokine activity. Eur J Cell Biol. 2011;90(6-7):476-483.
[29] TRAVIS MA, SHEPPARD D. TGF-β activation and function in immunity. Annu Rev Immunol. 2014;32:51-82.
[30] JOHNSTON CJ, SMYTH DJ, DRESSER DW, et al. TGF-β in tolerance, development and regulation of immunity. Cell Immunol. 2016;299:14-22.
[31] ZILBERBERG L, TODOROVIC V, DABOVIC B, et al. Specificity of latent TGF-β binding protein (LTBP) incorporation into matrix: Role of fibrillins and fibronectin.J Cell Physiol. 2012;227(12): 3828-3836.
[32] WATERS JP, POBER JS, BRADLEY JR. Tumour necrosis factor in infectious disease. J Pathol. 2013;230(2):132-147.
[33] SEN A, PAINE SK, CHOWDHURY IH, et al. Assessment of gelatinase and tumor necrosis factor-α level in the vitreous and serum of patients with Eales disease: Role of inflammation- mediated angiogenesis in the pathogenesis of Eales disease. Retina.2011;31(7):1412-1420.
[34] LIMB GA, DANIELS JT, PLEASS R, et al. Differential expression of matrix metalloproteinases 2 and 9 by glial Müller cells: Response to soluble and extracellular matrix-bound tumor necrosis factor-alpha. Am J Pathol. 2002;160(5):1847-1855.
[35] DIGIROLAMO N, INDOH I, JACKSON N, et al. Human mast cell-derived gelatinase B (matrix metalloproteinase-9) is regulated by inflammatory cytokines: Role in cell migration. J Immunol. 2006; 177(4):2638-2650.
[36] SOKOL CL, LUSTER AD. The chemokine system in innate immunity. Cold Spring Harb Perspect Biol. 2015;7(5):a016303.
[37] SAVINO W, MENDES-DA-CRUZ DA, GOLBERT DC, et al. Laminin-mediated interactions in thymocyte migration and development. Front Immunol.2015;6:579.
[38] GAGGAR A, WEATHINGTON N. Bioactive extracellular matrix fragments in lung health and disease. J Clin Invest. 2016;126(9): 3176-3184.
[39] GORDON S. Pattern recognition receptors: Doubling up for the innate immune response. Cell. 2002;111(7):927-930.
[40] ABDULRODA M, FERNSTRAND AM, REDEGELD FA, et al. Thematrikine PGP as a potential biomarker in COPD. Am J Physiol Lung Cell Mol Physiol. 2015;308(11):L1095-L1101.
[41] MYDEL P, SHIPLEY JM, ADAIR-KIRK TL, et al. Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J Biol Chem. 2008;283(15): 9513-9522.
[42] TADDESE S, WEISS AS, JAHREIS G, et al. In vitro degradation of human tropoelastin by MMP-12 and the generation of matrikines from domain 24. MatrixBiol. 2009;28(2):84-91.
[43] NANDADASA S, FOULCER S, APTE SS, et al. The multiple, complex roles of versican and its proteolytic turnover by ADAMTS proteases during embryogenesis. Matrix Biol. 2014;35:34-41.
[44] HOPE C, FOULCER S, JAGODINSKY J, et al. Immunoregulatory roles of versican proteolysis in the myeloma microenvironment. Blood. 2016;128(5):680-685.
[45] 夏商,姜立铭,陈旭.组织工程技术应用于牙周膜再生研究进展[J].中国实用口腔科杂志,2016,9(9):557-560.
[46] ROSSO F, GIORDANO A, BARBARISI M, et al. From cell-ECM interactions to tissue engineering. J Cell Physiol. 2004;199(2): 174-180.
[47] DU J, CHEN H, QING L, et al. Biomimetic neural scaffolds: A crucial step towards optimal peripheral nerve regeneration. Biomater Sci. 2018;6(6):1299-1311.
[48] INGULLI E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol. 2010;25(1):61-74.
[49] FISHMAN JM, LOWDELL MW, URBANI L, et al. Immunomodulatory effect of a decellularized skeletal muscle scaffold in a discordant xenotransplantation model.Proc Natl Acad Sci U S A. 2013;110(35):14360-14365.
[50] RANA D, ZREIQAT H, BENKIRANE-JESSEL N, et al. Development of decellularized scaffolds for stem cell-driven tissue engineering. J Tissue Eng Regen Med. 2015;11(4):942-965.
[51] CHENG CW, SOLORIO LD, ALSBERG E. Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv. 2014;32(2): 462-484.
[52] WANG Y, BAO J, WU X, et al. Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization. Sci Rep.2016;6:24779.
[53] TAJIMA A, PRADHAN I, GENG X, et al. Construction of thymus organoids from decellularized thymus scaffolds. Methods Mol Biol. 2019;1576:33-42.
[54] VELASCO MA, NARVÁEZ-TOVAR CA, GARZÓN-ALVARADO DA. Design, materials, and mechanobiology of biodegradable scaffolds for bone tissue engineering. Biomed Res Int.2015; 2015:729076.
[55] SKÓRA J, PUPKA A, DOROBISZ A, et al. Evaluation of the humoral and cellular immune responses after implantation of a PTFE vascular prosthesis. Postȩpy Hig Med Dosw(Online). 2012;66:469-474.
[56] NAJAR M, RAICEVIC G, FAYYAD-KAZAN H, et al. Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. Cytotherapy. 2016;18(2):160-171.
[57] NA S, ZHANG H, HUANG F, et al. Regeneration of dental pulp/dentine complex with a three-dimensional and scaffold-free stem-cell sheet-derived pellet. J Tissue Eng Regen Med. 2013; 10(3):261-270.
[58] YANG Y, LIN H, SHEN H, et al. Mesenchymal stem cell-derived extracellular matrix enhances chondrogenic phenotype of and cartilage formation by encapsulated chondrocytes in vitro and in vivo. Acta Biomater. 2018;69:71-82.
[59] HOCH AI, MITTAL V, MITRA D, et al. Cell-secreted matrices perpetuate the bone-forming phenotype of differentiated mesenchymal stem cells. Biomaterials. 2015;74:178-187.
[60] GU Y, LI Z, HUANG J, et al. Application of marrow mesenchymal stem cell-derived extracellular matrix in peripheral nerve tissue engineering. J Tissue Eng Regen Med.2017;11(8):2250-2260.
|